Differential transcriptomic and cytotoxic responses to polyvinylpyrrolidone-stabilized silver nanoparticles in breast cancer cells and human dermal fibroblasts Authors: Jesús Gabriel González-Vega, Emilio Fabian-Ortiz, Erika Magallón-Gayón, Eduardo Vázquez-Garza, Juan Pablo Torres-Esquivel, Silvia Hinojosa-Alvarez, Jesús Hernandez-Perez, Nina Bogdanchikova, Alexey Pestryakov, Rocio Alejandra Chavez-Santoscoy Published: 2026 ABSTRACT AbstractSilver nanoparticles (AgNPs) are widely used in industrial and biomedical applications due to their antimicrobial and anticancer properties. However, the molecular mechanisms underlying their cellular effects remain incompletely understood, limiting their safe implementation. Next-generation sequencing (NGS) enables high-throughput transcriptomic profiling, providing valuable insights into the cellular responses triggered by nanoparticle exposure. In this study, we evaluated the cytotoxic and transcriptomic effects of two polyvinylpyrrolidone (PVP)-stabilized AgNP formulations (AgNP1 and AgNP2) in human dermal fibroblasts (HDFa) and breast cancer cells (MCF7) across a range of concentrations (5–200 µg/mL). Cell viability assays indicated differential bioactivity to AgNP exposure depending on cell type and nanoparticle formulation. Comparative transcriptomic analysis revealed that both AgNP formulations disrupted cellular homeostasis through the dysregulation of pathways associated with protein folding, cytoskeletal organization, and endoplasmic reticulum function. Stress-related genes such as HSPA1A, HSPA1B, and HMOX1 were significantly upregulated following treatment. Overall, AgNP exposure induced cell type–dependent transcriptional responses, characterized by proteostasis-related stress pathways in HDFa cells and enhanced RNA processing and gene expression regulation in MCF7 cells. Gene Ontology enrichment analysis further highlighted alterations in biological processes related to protein refolding and cellular stress responses, as well as molecular functions associated with ATP-dependent protein-folding chaperones. Functional assays did not reveal significant increases in intracellular ROS levels or detectable apoptotic or necrotic cell death. Instead, the transcriptomic profiles suggest that AgNP exposure predominantly activates cellular stress responses associated with proteostasis and protein quality control. These findings provide new insights into the complex cellular responses triggered by PVP-stabilized AgNP formulations and highlight the importance of nanoparticle physicochemical properties and cell-type–dependent responses in determining biological outcomes. The results highlight the value of transcriptomic approaches to uncover early mechanistic responses to nanomaterials beyond conventional cytotoxicity endpoints.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-48025-0.Keywords: PVP-coated silver nanoparticles, Omics, HDFa cells, MCF7 cells, Transcriptomic analysis, Biological pathways, Differential expression of genes, RNA-seq, Next-generation sequencingSubject terms: Biochemistry, Biological techniques, Biotechnology, Cancer, Cell biology, Molecular biology Introduction Nanotechnology involves materials with at least one external dimension or internal structure at the nanoscale (1–100 nm). Due to their size, these materials exhibit unique physical, chemical, and biological properties, enabling their application across various fields of modern technology. Among these materials, silver nanoparticles (AgNPs) are widely used in several fields, including the biomedical and food industries, where they are mainly exploited as antimicrobial agents1. Recently, AgNPs have gained attention in cancer treatment, particularly as drug carriers for targeted chemotherapy. Their ability to enhance drug bioavailability, enable controlled release, and reduce off-target toxicity makes them promising agents for diseases like breast cancer2. However, concerns regarding their in vivo toxicity remain a challenge and require further investigation. In this regard, and given their expanding biomedical applications, there is an urgent need to comprehensively evaluate the potential toxicological effects of AgNPs. Their nanoscale dimensions and enhanced surface reactivity allow them to interact with biological targets to a greater extent than bulk materials, raising concerns about their safety profile3. Moreover, recent in vitro studies suggest that the toxicity of nanoparticles (NPs) is not only influenced by factors such as size and surface reactivity but also from coating agent, surface modifications, and agglomeration4. Furthermore, different cell types exhibit varying susceptibility to the oxidative stress induced by NPs, indicating potential differential responses in cytotoxicity mechanisms5. Although most in vitro studies primarily rely on cell viability assays, such as the 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2 H-tetrazolium (MTS) assay or the lactate dehydrogenase release (LDH) assay, these methods provide only limited insight into the complex interactions between cells and NPs. In contrast, Omics approaches, particularly transcriptomics, have emerged as powerful tools for the toxicological evaluation of NPs, enabling a detailed assessment of gene expression changes and offering a deeper understanding of the molecular mechanisms driving cytotoxic responses6. Nevertheless, while transcriptomic analyses have been increasingly applied to NP research, few studies have systematically compared the transcriptomic profiles between cancer and non-cancer cell lines exposed to AgNPs7. To investigate whether subtle formulation-dependent physicochemical differences between closely related AgNP systems translate into distinct cellular responses, we compared the effects of two PVP-coated silver nanoparticle formulations, AgNP1 and AgNP2 (previously described as Argovit-C and Argovit 3). These formulations share the same synthesis method but differ in the molecular weight of the stabilizing polymer, with Argovit-C coated with PVP K15 (8–12 kDa) and Argovit 3 with PVP K17 (10–16 kDa), while maintaining a similar [Ag]/[PVP] ratio that has been associated with high colloidal stability and reproducible biological responses8,9. These formulations were selected based on previous studies evaluating Argovit®-based AgNPs with different physicochemical characteristics and an initial screening performed in our laboratory to identify nanoparticles with stable physicochemical properties and measurable biological responses suitable for transcriptomic analysis8–10. Human dermal fibroblasts (HDFa) were selected as a representative non-tumor human cell model relevant to potential occupational or environmental exposure routes, such as dermal contact. In parallel, Michigan Cancer Foundation-7 (MCF-7) breast cancer cells were used as a well-established tumor model to assess whether subtle formulation differences could produce differential cytotoxic and transcriptomic responses between normal and malignant human cells. By combining functional cytotoxicity assays with transcriptomic profiling using next-generation sequencing, this study aims to bridge phenotypic observations with their underlying molecular responses at the level of gene expression. In addition, the cytotoxic contribution of silver ions and PVP was evaluated at concentrations equivalent to those present in AgNP1 and AgNP2, allowing the assessment of whether the observed effects are driven by the nanoparticle structure itself or by its individual components. Methods Silver nanoparticle formulations (AgNP1 and AgNP2) For simplicity in this study, we will use the terms AgNP1 and AgNP2 formulations to refer to previous formulations that have been widely discussed in the literature as Argovit-C and Argovit 3, respectively. These formulations were kindly donated by Professor Dr Vasily Burmistrov from the Scientific and Production Center Vector-Vita (Novosibirsk, Russia). Both formulations are preparations of highly dispersed AgNPs with an overall concentration of 200 mg/ml (20%) of PVP-coated AgNPs in water. The content of metallic silver in Argovit preparation is 12 mg/ml, which is stabilized with 188 mg/ml of PVP. Solutions were prepared in DMEM media without supplements and were kept at 4 °C in the dark. Prior to the experiments described in this study, an initial screening was performed using several Argovit®-based AgNP formulations differing in physicochemical characteristics, including variations in PVP molecular weight and nanoparticle size distribution. This preliminary evaluation aimed to identify formulations displaying stable physicochemical properties and measurable biological responses suitable for transcriptomic analysis. Based on this screening, two representative formulations (AgNP1 and AgNP2) were selected for detailed characterization and biological evaluation in the present study. Both formulations fall within a previously reported [Ag]/[PVP] ratio range associated with high colloidal stability and controlled nanoparticle dispersion8. Physicochemical characterization DLS: The average size, size distribution, and polydispersity index (PDI) of the AgNP1 and AgNP2 formulations were measured by dynamic light scattering (Zetasizer DTS 1060, Malvern Instruments, Malvern, UK) using the Zetasizer software (Malvern Instruments, Malvern, UK). The nanoparticles were diluted 1:10 in cell culture media, and then the samples were sonicated for 10 min before reading at a refractive index of 1.450 and with dispersion optics at 173° (λ = 633 nm). The experiments were performed in triplicate. Uv-Vis: A UV-Visible spectrophotometer was employed to characterize the absorption spectrum of both formulations of silver nanoparticles to confirm the presence of the surface plasmon resonance (SPR) phenomenon present in metallic nanoparticles. The instrument was calibrated using a blank solvent (deionized water) before each measurement. A quartz cuvette with a 1 cm path length was used for all measurements to ensure a consistent optical path length. Silver nanoparticles were diluted in water 1:10 and were carefully loaded into the cuvette, and the baseline was adjusted using the blank solvent. The wavelength range was set from 200 nm to 800 nm. Cell culture Human breast cancer (MCF7) and Primary Dermal Fibroblast (HDFa) were purchased by ATCC and grown on Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 1% (v/v) penicillin/streptomycin and 7% of Fetal Bovine Serum (FBS), cell cultures were maintained at 37 °C in a humidified atmosphere of 5% CO2 and cultured on T25 Corning® cell culture flasks. HDFA and MCF7 were seeded in the separate 96 multi-well plates for the MTS assay and 6 multi-well plates for RNA extraction and were allowed to be attached for 24 h, afterward culture medium was removed, and cells were washed twice with PBS, afterward a solution containing 0.25% Trypsin/EDTA was added, and cells were maintained for 5 min in the CO2 incubator. Trypsin action was stopped by the addition of equal volumes of DMEM cell medium containing 5% FBS. Finally, the resulting cellular density was determined using trypan blue solution (Corning, Corning, NY, USA) and Countess Automated Cell Counter (Invitrogen, Carlsbad, CA, USA), and the samples were adjusted to the cell density needed to start each specific experiment. MTS assay Cell viability was measured using CellTiter 96® AQueous One Solution Cell Proliferation Assay (Promega, Madison, WI, USA). The protocol was performed according to the manufacturer’s instructions. Briefly, 96 well plates containing a concentration of 5 × 105 cells/mL were seeded for 24 h and later treated with different concentration of AgNPs (5 µg/ml to 200 µg/ml) using ratio between PVP and Ag contents in AgNPs (94% and 6% wt. respectively) being incubated for 24 h at growth conditions described above. Afterward, 20 µL of Cell Titer 96 Aqueous One Solution Kit® (Promega Corporation, Madison, WI, USA) was added to the cells, and subsequently incubated for 30 min. Finally, absorbance was measured at 490 nm on a 96-well plate reader (Synergy HT, Bio-Tek, Winooski, VT, USA). Cell viability was calculated by dividing the absorbance of the treated cells by the absorbance of the control, untreated cells, and this ratio was expressed as a percentage. To assess potential nanoparticle interference with the colorimetric signal, additional control wells containing culture medium, MTS reagent, and each treatment condition (AgNPs, PVP, and AgNO₃) in the absence of cells were included. These values were used for background correction to minimize non-specific absorbance contributions. All experiments were performed by triplicate. Data are presented as mean ± standard deviation analyzed and plotted using GraphPad Prism 10 software. IC50 calculations The data were normalized to untreated control and analyzed using GraphPad Prism 10 software. Dose-response curves were generated for each treatment, and the half-maximal inhibitory concentration (IC50) was calculated using a non-linear regression model with variable slope (four parameters). IC50 values were determined for both MCF7 and HDFa cell lines to evaluate the cytotoxic effects of each formulation. RNA processing and library preparation Nanoparticles were diluted in DMEM media to perform the stimulation at appropriate concentrations. HDFa and MCF7 cells were allowed to attach for 24 h on 6-well plates and grown at a density of 5 × 105 cells per well. Subsequently, cells were stimulated with the diluted nanoparticles to a final concentration of 25 µg/mL, while PVP (control sample) was used at 23.5 µg/mL and silver nitrate (AgNO3, control sample) at 1.5 µg/mL. The concentration of 25 µg/mL used for RNA sequencing was selected based on an initial concentration screening experiment, as it induced the strongest transcriptomic response while maintaining acceptable cell viability, in accordance with international omics guidelines recommending the use of non cytotoxic to moderately cytotoxic concentrations for mechanistic transcriptomic analyses11. Cells were incubated at 37 °C in a humid atmosphere with 5% CO2 for an additional 24 h. Total RNA was extracted using silica purification columns from the RNeasy Mini Kit (Qiagen), following the manufacturer’s protocols. The quality and quantity of the RNA samples were assessed using a Qsep Analyzer and Invitrogen’s Qubit RNA HS assay kit. Only samples with an RNA Integrity Number (RIN) above 9.0 were processed for library preparation using the TruSeq Stranded Total RNA kit (Illumina, San Diego, CA, USA), strictly following the manufacturer’s instructions. The constructed libraries were sequenced on an Illumina NovaSeq 6000 platform using an S2 flow cell in a 101 bp paired-end configuration. Three independent biological replicates were performed for each experimental condition. Bioinformatic analysis The quality of raw reads was assessed using FastQC12 to determine sequencing quality. All reads passed the quality filters. Reads were aligned to the human reference genome (GRCh38) using STAR13. After mapping, gene-level quantification was performed, generating a count table with the HTSeq package14. This count table was used for further differential expression analysis. Both STAR and HTSeq were executed within OmicsBox15. Differential gene expression (DGE) among groups was conducted using the iDEP 2.0 online package16. The false discovery rate was set at FDR < 0.05, and genes with an absolute log2 fold change greater than 1 (|log₂FC| > 1) were considered. Gene Ontology analysis was performed using AdvaitaBio iPathwayGuide software17,18. Pathway analysis was performed using Ingenuity Pathway Analysis (IPA) software19. Intracellular ROS measurement Intracellular reactive oxygen species (ROS) levels were measured using the MAK143 ROS Detection Kit (Sigma-Aldrich) according to the manufacturer’s instructions with minor modifications. Briefly, HDFa and MCF7 cells were seeded in black 96-well plates at a density of 5 × 10⁴ cells per well and allowed to attach for 24 h. Cells were then exposed for an additional 24 h to AgNP1 and AgNP2 (25 µg/mL), PVP (23.5 µg/mL), and AgNO₃ (1.5 µg/mL), corresponding to the concentrations used for transcriptomic analyses. Following treatment, 100 µL of the ROS detection master mix was added to each well, and cells were incubated for 1 h at 37 °C in the dark. Subsequently, 20 µL per well of the corresponding 11x test compounds were added according to the manufacturer’s protocol. Hydrogen peroxide (H₂O₂, 200 µM for 30 min) was used as a positive control for ROS induction. Fluorescence was measured using a microplate reader λex = 490/λem = 525 nm. To minimize potential nanoparticle interference with fluorescence measurements, appropriate blank, media, and nanoparticle-only control wells were included and used for background correction. All experiments were performed by triplicate. Data are presented as mean ± standard deviation. Apoptosis and necrosis analysis by flow cytometry HDFa and MCF7 cells were seeded in 6-well plates at a density of 5 × 10⁵ cells per well to ensure sufficient cell numbers for flow cytometry analysis. Cells were allowed to attach for 24 h and subsequently exposed for an additional 24 h to AgNP1 and AgNP2 (25 µg/mL), PVP (23.5 µg/mL), and AgNO₃ (1.5 µg/mL), corresponding to the concentrations used for transcriptomic analyses. Following treatment, cells were washed once with 1 mL of 1× PBS and detached using 300 µL of trypsin per well. Trypsinization was carried out for 5 min at 37 °C and neutralized with 1 mL of complete culture medium. Cells were then collected and centrifuged at 300 × g for 10 min. The resulting cell pellet was washed with PBS and resuspended for staining. For apoptosis/necrosis analysis, cells were stained with 5 µL of Alexa Fluor 488-conjugated Annexin V (Thermo Fisher Scientific, Cat. No. V13241) for 15 min at room temperature in the dark. After staining, cells were washed by centrifugation (300 × g, 10 min) and resuspended in 250 µL of PBS. Subsequently, 10 µL of Propidium Iodide (PI; 1.0 mg/mL, Sigma-Aldrich, Cat. No. P3566) was added 10 min prior to acquisition. Data acquisition was performed using a CytoFLEX flow cytometer (Beckman Coulter, B53000) equipped with 488 nm (blue) and 638 nm (red) lasers. Alexa Fluor 488 fluorescence was detected using a 525/40 nm bandpass filter, while PI fluorescence was collected using a 610/20 nm bandpass filter. For each sample, 50,000 singlet events were acquired. Doublets were excluded by gating based on forward scatter height versus area (FSC-H vs. FSC-A). Data analysis was performed using CytExpert and Kaluza software (Beckman Coulter). Cell populations were classified as viable (Annexin V⁻/PI⁻), early apoptotic (Annexin V⁺/PI⁻), late apoptotic (Annexin V⁺/PI⁺), or necrotic (Annexin V⁻/PI⁺). All experiments were performed by triplicate. Data are presented as mean ± standard deviation. Results and discussion Physicochemical characterization Dynamic light scattering (DLS) analysis revealed hydrodynamic mean diameters of 116.67 ± 1.62 nm for AgNP1 and 57.92 ± 0.64 nm for AgNP2 (Table 1). The polydispersity index (PDI) values of 0.278 ± 0.004 and 0.278 ± 0.004 for the AgNP1 and AgNP2 formulations, respectively, indicate a moderately homogeneous size distribution for both formulations. UV-Visible spectrometry showed a single surface plasmon resonance peak at 420 nm for AgNP1, whereas AgNP2 exhibited two distinct peaks at 415 nm and 450 nm (Fig. 1), consistent with the optical properties of silver-based nanoparticles. The presence of multiple peaks in the UV-Visible spectrum of AgNP2, along with its smaller hydrodynamic diameter, indicates a potential degree of aggregation. These physicochemical properties were calculated in previous studies for AgNP1 (as Argovit-C) and AgNP2 (as Argovit 3), presenting a slight variation8,9. In addition, these studies report average metallic core diameters of 14.95 ± 10.1 nm and 19.0 ± 9.3 nm for AgNP1 and AgNP2, respectively. Table 1Hydrodynamic diameters for AgNP1 and AgNP2.FormulationHydrodynamic diameter (nm)Polydispersity indexAgNP1116.67 ± 1.620.303AgNP257.92 ± 0.640.275 Hydrodynamic diameters for AgNP1 and AgNP2. A) UV-Visible spectrophotometry of AgNP1, AgNP2, AgNO3 and PVP. HDFa cell viability after exposure to AgNP1, AgNP2, AgNO3, and PVP HDFa cells represent a relevant model for evaluating nanoparticle cytotoxicity in normal human tissues due to their role in extracellular matrix production and tissue repair. In the present study, exposure to both AgNP formulations produced a concentration-dependent decrease in HDFa viability after 24 h (Fig. 2A). Quantitative analysis of the dose–response curves revealed IC50 values of 238.5 µg/mL for AgNP1 and 202.6 µg/mL for AgNP2 in HDFa cells (Table 2; Fig. 1S-A, indicating slightly higher cytotoxicity for the AgNP2 formulation. These differences suggest that subtle physicochemical variations between the two nanoparticle systems may influence their biological activity. Differences in hydrodynamic diameter and surface characteristics may modulate nanoparticle–cell interactions and cellular uptake, which can affect cytotoxic responses. HDFa cell viability after exposure to: A AgNP1, AgNP2, B AgNO3, where the concentration of silver as an element corresponds to that in PVP-AgNPs formulations. C PVP, where the concentration of silver as an element corresponds to that in AgNP1 and AgNP2 formulations. Statistical analysis for AgNP1 and AgNP2 was performed using two-way ANOVA followed by Tukey’s multiple comparisons test. For AgNO₃ and PVP, one-way ANOVA followed by Dunnett’s test was applied to compare each concentration with the negative control. Statistical significance is represented as follows: ns = not significant (p > 0.05); *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001. Only the comparisons between each treatment’s concentration and the negative control are displayed. Table 2IC50 calculations for AgNP1, AgNP2, AgNO3 and PVP on HDFa and MCF7 cells.AgNP formulationIC50 values on HDFa (µg/mL)IC50 values on MCF7(µg/mL)AgNP1238.5125.3AgNP2202.6173.4*Viability values below 50% were not reached. IC50 calculations for AgNP1, AgNP2, AgNO3 and PVP on HDFa and MCF7 cells. *Viability values below 50% were not reached. Our findings align with previous studies reporting that PVP-coated AgNPs can reduce fibroblast viability in a concentration-dependent manner20. However, the authors report an IC50 value of 4.17 µg/mL, thus indicating lower bioactivity for our tested formulations. This difference may be attributed to the presence of the PVP coating, which is known to improve nanoparticle stability and reduce direct interactions between metallic silver and cellular components. Conversely, Huang et al. 21 reported that uncoated AgNPs of similar size did not significantly reduce HDFa cell viability at concentrations around 21.57 µg/mL after shorter exposure periods, highlighting the influence of nanoparticle concentration and exposure duration on cytotoxic outcomes. The contribution of individual formulation components was further evaluated using equivalent concentrations of AgNO₃ and PVP. Silver ions produced a concentration-dependent reduction in HDFa viability (Fig. 2B), suggesting that ionic silver may play an important role in the overall cytotoxicity of AgNP formulations. However, the tested AgNO₃ concentrations did not reach a 50% reduction in cell viability, preventing the calculation of an IC50 value under the experimental conditions used in this study. In contrast, PVP exhibited minimal toxicity at concentrations equivalent to those present in the AgNP formulations (Fig. 2C), consistent with previous reports indicating that PVP is largely biocompatible at relevant exposure levels22. Overall, these differences imply that HDFa cells are less sensitive to AgNO3 and PVP stimulus in comparison with AgNP1 and AgNP2. MCF7 cell viability after exposure to AgNP1, AgNP2, AgNO3, and PVP MCF7 cells represent a well-established model for evaluating cytotoxic and antiproliferative responses in breast cancer. In the present study, exposure to both AgNP formulations resulted in a concentration-dependent reduction in MCF7 cell viability after 24 h (Fig. 3A). Quantitative analysis of the dose–response curves revealed IC50 values of 125.3 µg/mL for AgNP1 and 173.4 µg/mL for AgNP2 (Table 2; Fig. 1S-B), indicating slightly higher cytotoxicity for AgNP1 in this cell line. At lower concentrations, MCF7 cells exhibited a modestly increased bioactivity to AgNP2; however, this trend was not maintained at higher concentrations, suggesting that the relative biological activity of the formulations may depend on exposure levels. MCF7 cell viability after exposure to: A AgNP1, AgNP2, B PVP, where the silver content as an element corresponded to the silver content in AgNP1 and AgNP2 formulations, C AgNO3, where the silver content as an element corresponded to the silver content in AgNP1 and AgNP2 formulations. Statistical analysis for AgNP1 and AgNP2 was performed using two-way ANOVA followed by Tukey’s multiple comparisons test. For AgNO₃ and PVP, one-way ANOVA followed by Dunnett’s test was applied to compare each concentration with the negative control. Statistical significance is represented as follows: ns = not significant (p > 0.05); *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001. Only the comparisons between each treatment’s concentration and the negative control are displayed. Previous studies on a similar PVP-AgNPs formulation with a size of 35 nm confirmed this high bioactivity against MCF7 cells, with an IC50 value as low as 3.06 µg/mL after 24 h of exposure23. Since the average metallic core diameters of AgNP1 and AgNP2 have been reported as 14.95 ± 10.1 nm and 19.0 ± 9.3 nm, respectively, their lower bioactivity compared to values reported in the literature may be attributed to a size-dependent effect8,9. Overall, these findings indicate that subtle formulation-dependent differences can modulate cytotoxic responses in cancer cells. The contribution of silver ions was further evaluated using AgNO₃ at concentrations equivalent to the silver content present in the nanoparticle formulations. AgNO₃ induced a significant reduction in MCF7 cell viability at concentrations ≥ 1.5 µg/mL (Fig. 3B), although viability values below 50% were not reached under the tested conditions, these results are consistent with previous reports indicating an IC₅₀ of approximately 15 µg/mL after 24 h of exposure on MCF7 cells. This suggests that the absence of cytotoxicity for AgNO3 in our experiments can be explained by the fact that the tested concentrations did not reach the reported IC₅₀ threshold24. In addition, methodological differences may also contribute to these discrepancies, since the MTT and MTS assays differ in their sensitivity for detecting cell viability. Similarly, the effect of the PVP coating was assessed using concentrations representative of those present in the AgNP formulations. No statistically significative reduction in cell viability compared to control was observed at all tested PVP concentrations, confirming the negligible role of the PVP coating in AgNP1 and AgNP2 induced toxicity (Fig. 3C). This observation is consistent with the known biocompatibility of PVP, which has been widely reported to exhibit low toxicity due to its chemical stability, high solubility, and limited bioaccumulation25. Together with the results obtained in HDFa cells, these findings suggest that PVP alone does not account for the cytotoxic effects observed for the nanoparticle formulations. Transcriptomic analysis on HDFa cells after exposure to AgNP1 and AgNP2, AgNO3 and PVP The transcriptomic effects of silver nanoparticle treatments in HDFa cells for AgNP1 report that among a total of 26,496 measured genes, 703 were differentially expressed, finding 246 downregulated genes and 457 upregulated genes (Fig. 2S-A). In contrast, AgNP2 elicited a more limited response, with 176 DEGs out of 26,268 genes (70 upregulated, 106 downregulated) (Fig. 2S-B). PVP treatment resulted in 344 DEGs from 25,147 genes (189 upregulated, 155 downregulated) (Fig. 2S-C), while AgNO3 affected 259 of 25,147 genes (139 upregulated, 120 downregulated) (Fig. 2S-D). Notably, overlap analysis revealed a limited number of shared DEGs between treatments, with only 52 genes common to both AgNP formulations and minimal overlap with AgNO₃ and PVP (Fig. 4S-A). These findings indicate that, despite similar composition, AgNP1 and AgNP2 trigger distinct molecular responses, suggesting that subtle physicochemical differences between formulations translate into differential cellular stress pathways. Differential expression of genes and Gene Ontology analysis of HDFa cells exposed to AgNP1, AgNP2, PVP and AgNO3 Gene Ontology analysis revealed that AgNP1 exposure predominantly affected biological processes (BP) associated with protein folding and proteostasis (Fig. 4A). The upregulation of heat shock proteins (HSPA1A, HSPA1B, HSPA1L) and enrichment of processes such as protein refolding and response to unfolded protein suggest activation of a proteotoxic stress response. These stress related proteins can act as molecular chaperones facilitating protein folding, refolding, and assembly and the enrichment of these processes suggests that AgNP1 may induce proteotoxic stress by disrupting normal protein folding, with cells responding by recruiting HSPs to mitigate the damage. Notably, prior studies have identified these proteins as potential biomarkers in nanotoxicity assessment26. Circos plots representing Gene Ontology (GO) biological processes significantly enriched in the HDFa cell line following treatment with silver nanoparticles. The plots illustrate the relationship between differentially expressed genes and their associated GO terms for A AgNP1 and B AgNP2, C AgNO3, and D PVP. Additionally, the concurrent enrichment of cytoplasmic translation and ‘de novo’ post-transcriptional protein folding, together with the downregulation of TOR1A and key translational components (e.g., RPSA, EIF2S3), supports the presence of endoplasmic reticulum (ER) stress and translational imbalance. In fact, their downregulation has been associated with ER stress sensitization, indicating that AgNP1 exposure may primarily induce a proteostasis stress response, rather than a classic oxidative stress-driven mechanisms27. The upregulation of Heme oxygenase 1 (HMOX1) can further support the idea of a broader cellular stress response. Although HMOX1 is often associated with oxidative stress, its induction may also reflect broader stress adaptation mechanisms linked to protein damage and cellular homeostasis. In contrast, the downregulation of NOS3 suggests modulation of nitric oxide signaling, potentially as part of a controlled stress response. In contrast to AgNP1, AgNP2 exposure was associated with biological processes related to transcriptional regulation and immune-related signaling (Fig. 4B). Enrichment of RNA polymerase II–mediated transcription and deregulation of transcription factors such as FOXN1 and EGR1 suggest that AgNP2 primarily affects gene regulatory networks rather than protein homeostasis. Additionally, enrichment of immune-related processes, including cytokine regulation and opsonization, together with upregulation of SPON2 and RIPK2, indicates activation of signaling pathways associated with cell signaling and inflammatory responses. These findings suggest that AgNP2 induces a transcription-driven adaptive response, distinct from the proteostasis disruption observed for AgNP1. AgNO₃ treatment affected fundamental cellular processes, particularly those related to translation and metabolism (Fig. 4C). However, in contrast to AgNP1, most genes associated with cytoplasmic translation were downregulated, suggesting an overall suppression of protein synthesis rather than activation of adaptive protein folding mechanisms. This difference highlights that ionic silver induces a different cellular response profile, likely associated with cellular stress and metabolic disruption rather than targeted proteostasis pathways. In contrast, PVP treatment produced relatively modest transcriptomic changes, primarily affecting pathways related to cell signaling and metabolic regulation (Fig. 4D). The enrichment of processes associated with lipid metabolism and intracellular signaling suggests adaptive cellular responses rather than direct cytotoxic effects. Together with the minimal impact observed in viability assays, these findings support the conclusion that PVP does not drive the biological effects observed for in AgNP formulations. Ingenuity Pathway Analysis for HDFa cells exposed to AgNP1, AgNP2, PVP and AgNO3 Ingenuity Pathway Analysis revealed that both AgNP1 and AgNP2 induce coordinated activation of pathways related to cellular stress adaptation, translation control, and structural remodeling in HDFa cells (Fig. 5A and B). Notably, despite differences at the gene level, both AgNP formulations converged on common signaling nodes, including PKA, EIF2, and mTOR-related pathways, suggesting activation of an integrated stress response aimed at maintaining cellular homeostasis under nanoparticle-induced stress. Biological pathways significantly enriched in the HDFa cell line following treatment with silver nanoparticles. The plots display enriched pathways associated with differentially expressed genes, highlighting key molecular mechanisms based on statistical significance using –log (p-value), with values below 1.3 considered not significant for A AgNP1 and B AgNP2. C AgNO₃ (ionic silver control), and D PVP (nanoparticle coating control). Color coding distinguishes treatment groups: blue (AgNP1), purple (AgNP2), green (AgNO₃), and gold (PVP). Notably, AgNP1 and AgNP2 display significant upregulation of protein kinase A (PKA) signaling as the top biological pathway for HDFa cells. PKA is a key intracellular effector of cAMP signaling involved in the regulation of cellular metabolism, cytoskeletal organization, and gene expression28. Importantly, previous studies have shown that ER stress can activate PKA signaling, leading to downstream phosphorylation of the eukaryotic initiation factor 2 (EIF2) pathway29. Consistently, EIF2 signaling was also upregulated in response to both AgNP formulations in this study. The concurrent activation of PKA, EIF2, and eIF4/p70S6K pathways supports the induction of translation reprogramming mechanisms, in which global protein synthesis is attenuated while the selective translation of stress-responsive genes is maintained. This coordinated response is characteristic of proteostasis imbalance, allowing cells to adapt to protein-folding stress conditions. These findings agree with the Gene Ontology analysis, further supporting that AgNP exposure primarily disrupts protein homeostasis rather than inducing classical cytotoxic pathways. EIF2 is a GTP-binding protein that regulates global and specific mRNA translation by promoting the initiation specific form of met-tRNA onto the ribosome. In fact, it has been observed that this pathway can enhance the inhibition of protein synthesis, while promoting the translation of stress response mRNAs, enhancing cell survival30. Moreover, the regulation of the eIF4 and p70S6k signaling pathway, an important canonical pathway involved in translation regulation and cellular growth, was observed to be upregulated by both AgNP1 and AgNP2 formulations in this study. This further reinforces the idea of a selective translation of proteins and translation factors in HDFa to circumvent cytotoxicity. Pathways associated with DNA synthesis and repair, including ribonucleotide reductase signaling and BRCA1-mediated DNA damage response, were also enriched. While these pathways are commonly associated with genotoxic stress, their activation may also reflect adaptive mechanisms aimed at maintaining genomic integrity under cellular stress conditions, rather than direct evidence of DNA damage. This interpretation is supported by previous studies reporting that DNA damage response pathways can occur in the absence of direct genotoxicity assessment as part of a broader cellular stress adaptation mechanism to AgNPs31. However, these findings are based on transcriptomic data and do not constitute direct evidence of genotoxicity. Further studies, such as DNA damage ELISA, micronucleus assays, or cell cycle analysis, will be required to determine whether AgNP exposure induces actual DNA damage under these conditions. Additionally, alterations in actin cytoskeleton signaling, RHOGDI signaling and integrin-linked kinase (ILK) signaling pathways were also observed, suggesting that AgNP1 and AgNP2 can further induce cytoskeletal reorganization. It is well known that cytoskeletal reorganization is a complex biological process that depends on downstream mediators such as proteins of the RhoA family and signaling mediators that connect integrins with the cytoskeleton, like ILK. Similarly to our results, other authors report that similar concentrations of ∼21.57 µg/mL of AgNPs of ∼20 nm can induce the upregulation of the actin cytoskeleton pathway as the main mechanism of cytotoxicity in HDFa cells21,32. In addition, the authors identify that AgNPs can also induce metabolic disturbance and subsequent cell death by apoptosis by upregulating other important biological pathways such as insulin signaling and MAPK signaling. These processes are typically associated with changes in cell morphology, adhesion, and intracellular signaling, and may reflect cellular attempts to adapt to altered mechanical and biochemical micronvironments induced by AgNP exposure. Importantly, apoptosis-related pathways were not significantly activated in response to either AgNP formulation. Instead, enrichment of senescence and autophagy-related pathways suggests that HDFa cells may undergo a sublethal adaptive response, potentially involving cell cycle arrest and activation of intracellular recycling mechanisms. The concurrent activation of AMPK and mTOR signaling is consistent with pathways previously associated with cytoprotective autophagy and cellular stress adaptation in cells exposed to AgNP formulations33. AgNO₃ treatment partially share some of the pathways observed for both of the AgNP formulations, including PKA, cytoskeleton, and metabolic signaling (Fig. 5C). However, the stronger enrichment of DNA damage-related pathways, particularly BRCA1 signaling, suggests a more pronounced impact on genomic stability. These differences indicate that ionic silver and AgNP formulations elicit overlapping but not identical molecular responses, supporting the contribution of physicochemical properties at the nanoscale to the overall observed cellular effects. In contrast, PVP treatment induced comparatively conservative pathway alterations, primarily related to cytoskeletal organization and cell–cell interaction (Fig. 5D). The absence of significant activation of DNA damage or stress-response pathways further supports its limited contribution to the biological effects observed for the nanoparticle formulations. Overall, these results indicate that AgNP1 and AgNP2 do not primarily induce classical cytotoxic pathways such as apoptosis or oxidative stress but rather trigger a coordinated proteostasis-centered stress response, involving translation reprogramming, autophagy activation, and cytoskeletal remodeling. This integrated response may explain the cellular effects observed under subcytotoxic conditions, where transcriptional alterations can be detected in the absence of excessive cytotoxicity, highlighting the value of transcriptomic approaches to uncover early mechanistic responses beyond conventional viability assays. Transcriptomic analysis on MCF7 cells exposed to AgNP1, AgNP2, PVP and AgNO3 Transcriptomic analysis revealed distinct gene expression patterns in MCF7 cells following exposure to AgNP1, AgNP2, AgNO₃, and PVP (Fig. 3S). Briefly, in AgNP1, a total of 26,213 were measured from which 373 DEGs were identified, finding 202 genes downregulated and 171 genes upregulated (Fig. 3S-A). In contrast, AgNP2 elicited a smaller transcriptomic response with 285 DEGs from a total of 26,310 genes, where 205 and 80 genes were downregulated and upregulated, respectively (Fig. 3S-B). Moreover, 186 DEGs were identified out of a total of 25,838 in AgNO3-exposed cells, elucidating the downregulation of 90 genes and the upregulation of 96 genes (Fig. 3S-C). On the other hand, PVP exhibited 803 differentially expressed genes out of a total of 25,580 genes, of which 275 and 528 genes were found downregulated and upregulated respectively (Fig. 3S-D). Notably, overlap analysis revealed limited shared DEGs between treatments, with only 12 genes common to both AgNP formulations and minimal overlap with controls. Gene Ontology analysis of MCF7 cells exposed to AgNP1, AgNP2, PVP and AgNO3 Gene Ontology analysis revealed that, in contrast to HDFa cells, AgNP1 and AgNP2 predominantly affected biological processes related to post-transcriptional regulation and RNA processing (Fig. 6). Enrichment of pathways such as mRNA splicing, ribonucleoprotein complex biogenesis, and mRNA processing suggests that AgNP exposure in MCF7 cells primarily targets RNA metabolism and gene expression regulation, rather than protein-folding pathways. The downregulation of key splicing factors, including SRSF3, LUC7L3, and ZMAT2, further supports the disruption of RNA processing machinery. These alterations may reflect a regulatory mechanism by which cancer cells modulate gene expression and protein synthesis in response to NP-induced stress. Consistently, the enrichment of ribonucleoprotein complex biogenesis suggests an adaptive response directed at maintaining translational capacity under stress conditions. Circos plots representing Gene Ontology (GO) biological processes significantly enriched in the MCF7 cell line following treatment with silver nanoparticles. The plots illustrate the relationship between differentially expressed genes and their associated GO terms for A AgNP1 and B AgNP2, C AgNO3, and D PVP. Although both formulations affected RNA-related processes, AgNP1 showed stronger enrichment of ribonucleoprotein complex biogenesis, whereas AgNP2 exerted a more pronounced effect on mRNA splicing pathways. These differences suggest that subtle physicochemical variations between formulations may differentially influence the regulation of gene expression at the post-transcriptional level as exhibited in other studies involving the AgNPs34. In adittion, enrichment of pathways related to protein localization to the nucleus suggests active regulation of nucleocytoplasmic transport, a process essential for coordinating transcriptional responses. These findings further support the involvement of nuclear regulatory mechanisms in the cellular response to AgNP exposure35. AgNO₃ treatment similarly affected RNA processing pathways but also showed a more pronounced impact on metabolic processes, including tricarboxylic acid cycle–related pathways (Fig. 6C). This suggests that ionic silver may preferentially disrupt cellular metabolism, in addition to transcriptional regulation, indicating partially overlapping but distinct mechanisms compared to AgNP formulations. In contrast to the other stimulus, PVP treatment resulted in transcriptomic changes primarily associated with translation and biosynthetic processes (Fig. 6D), despite its negligible cytotoxic effect. As a negligible effect of cytotoxicity of PVP was observed for MCF7, and lower concentrations of AgNO3 exert a higher reduction in cell viability, we could infer that PVP coating on AgNP1 and AgNP2 can modulate nanosilver toxicity in MCF7 cells. In fact, it has been shown that PVP can enhance drug encapsulation and delivery to certain types of breast cancer without influencing cytotoxicity25. Overall, these results indicate that AgNP exposure induces cell type–dependent transcriptional responses, with HDFa cells primarily exhibiting proteostasis-related stress pathways, whereas MCF7 cells show a stronger modulation of RNA processing and gene expression regulation. These differences highlight the importance of cell-type in determining AgNP-induced molecular responses and suggest that subtle changes in the physicochemical properties of this NP formulations can engage distinct adaptive mechanisms depending on the biological system. Pathway analysis for MCF7 cells exposed to AgNP1, AgNP2, PVP and AgNO3 Ingenuity Pathway Analysis of MCF7 cells revealed that, despite their distinct cytotoxic responses, AgNP1 and AgNP2 activate partially overlapping molecular mechanisms with those observed in HDFa cells, particularly in pathways associated with cellular structure and stress adaptation (Fig. 7A and B). However, a key difference was the predominance of integrin-linked kinase (ILK) signaling in MCF7 cells, a pathway strongly associated with cancer progression, cytoskeletal organization, and signal transduction36. Concomitant modulation of integrins, mTOR, AMPK, small GTPases, actin cytoskeleton, and tight junction pathways suggests that both nanoparticle formulations induce cytoskeletal remodeling and alterations in cell adhesion dynamics. These changes are consistent with a cellular response to mechanical or structural stress rather than classical cytotoxic pathways. In line with this, previous studies have shown that nanoparticle-induced perturbations of the extracellular matrix and cytoskeleton can trigger adaptive responses linked to cell survival and structural reorganization37. Biological pathways significantly enriched in the HDFa cell line following treatment with silver nanoparticles. The plots display enriched pathways associated with differentially expressed genes, highlighting key molecular mechanisms based on statistical significance using –log (p-value), with values below 1.3 considered not significant for A AgNP1, B AgNP2, C PVP, D AgNO3. Mechanical stress and integrin deregulation have been linked to cell cycle arrest38. Our results seem to confirm this by demonstrating that AgNP1 and AgN2 can significantly induce alterations in cyclins and cell cycle regulation. Furthermore, AgNP1 showed the upregulation of the cell cycle: G1/S checkpoint regulation, and the role of CHK proteins in cell cycle checkpoint control. This finding may imply that AgNP1 and AgNP2 can stop cellular division as a mechanism to mitigate or repair damage. After entering the arrest on G1-phase, CHK2 interacts with breast cancer 1 (BRCA1) oncossupresor protein, which phosphorylation is essential for resolving DNA damage by the display of DNA repair mechanisms. These mechanisms include homologous recombination, non-homologous end joining, and nucleotide excision repair particularly in breast and ovarian cancers39. Thus, this can explain why the role of BRCA1 in DNA damage response was one of the most significatively altered pathways in MCF7 cells by action of both AgNP1 and AgNP2 formulations. Notably, exposure to AgNP1 and AgNP2 resulted in significant enrichment of autophagy and cellular senescence pathways, whereas no significant activation of the apoptosis pathway was detected in MCF7 cells. Similar to HDFa cells, these findings suggest that exposure to AgNP1 and AgNP2 may preferentially activate sublethal adaptive responses, including cell cycle arrest and intracellular recycling mechanisms, instead of activating classical cell death mechanisms. While the transcriptomic and pathway-level analyses indicate the involvement of these processes, they are based on gene expression patterns and do not constitute direct functional validation. Further studies at the protein and functional levels, including approaches such as Western blot analysis, checkpoint kinase activity and cell cycle assays, will be required to confirm these mechanisms. Additionally, nanoparticle uptake was not quantitatively assessed in this study, which represents a limitation when interpreting the mechanistic basis of the observed differential responses between cell types. Future studies incorporating quantitative uptake measurements will be necessary to determine the contribution of nanoparticle internalization to these cellular responses. When evaluating the effects of PVP and AgNO3, transcriptomic analysis revealed key distinctions between the two cell types. On one side, AgNO3 presented a more pronounced effect on DNA synthesis and regulation by the significant upregulation of role of BRCA1 in DNA damage response, role of CHK Proteins in cell cycle checkpoint control, cyclins and cycle regulation, mismatch repair in eukaryotes and base excision repair (BER) pathways (Fig. 7C). In addition, AgNO3 exposure upregulates sirtuin signaling pathway on MCF7 Cells. Sirtuins are enzymes from the class III histone deacetylases that utilize NAD+ as a co-substrate for their enzymatic functions. Sirtuins can display several functions, such as DNA repair, microtubule dynamics, cancer metabolism, and gene expression40. This could explain the alteration of biological processes such as TCA metabolism and mRNA processing, maybe as a response to an increased demand for NAD+ to survive AgNO3-induced stress on MCF7 cells. Unexpectedly, MCF7 cells exposed to PVP seem to overexpress the PKA pathway in MCF7 which has been associated with oncogenic activation and is frequently detected in breast cancer cells (Fig. 7D). As a non-significant toxicity for PVP was found, the presence of this pathway may be attributed to enhanced metabolism in MCF7 cells and not to specific responses to the polymer41. As such, further studies are needed to elucidate whether PVP directly modulates PKA signaling or if this effect arises as a secondary adaptation to cellular stress. Taken together, pathway-level analyses reveal that AgNP1 and AgNP2 induce convergent but cell type–dependent stress responses in HDFa and MCF7 cells. In both models, nanoparticle exposure led to the activation of pathways associated with cytoskeletal remodeling, metabolic regulation, and adaptive stress signaling, while classical apoptosis-related pathways were not prominently enriched at the transcriptomic level. However, clear differences were observed in the dominant regulatory mode of action exerted by each cell type. In HDFa cells, the response was primarily characterized by proteostasis imbalance and translation reprogramming, involving coordinated activation of PKA, EIF2, and mTOR-related pathways. In contrast, MCF7 cells exhibited a stronger engagement of cell cycle regulation, RNA processing, and integrin-mediated signaling pathways, suggesting a distinct adaptation centered on gene expression control and structural reorganization. Importantly, these findings indicate that the biological effects of AgNPs cannot be solely attributed to silver ions or polymer coating but rather arise from the enhanced physicochemical properties at the nanoscale which seems a suitable strategy to overcome macromolecular limitations in cancer cells. The predominance of adaptive and regulatory pathways over classical cytotoxic signaling supports a model in which AgNP exposure under sublethal conditions primarily triggers context-dependent stress adaptation mechanisms rather than immediate cell death responses. This mechanistic framework is further explored through functional assessments of oxidative stress and cell death pathways presented in the following section. Functional assessment of ROS production and apoptosis/necrosis To further investigate whether the transcriptional changes identified were associated with oxidative stress or classical cell death pathways, intracellular ROS levels and apoptosis/necrosis were assessed in HDFa and MCF7 cells following exposure to AgNP formulations. ROS measurements did not reveal significant increases in intracellular ROS levels compared with untreated controls under the tested conditions (Fig. 8). Functional assessment of oxidative stress and cell death pathways in HDFa and MCF7 cells following AgNP1 and AgNP2 exposure. Intracellular reactive oxygen species (ROS) levels measured in A HDFa and B MCF7 cells after treatment with AgNP1 and AgNP2 (25 µg/mL), PVP (23.5 µg/mL), and silver nitrate (AgNO₃, 1.5 µg/mL). Hydrogen peroxide (H₂O₂, 200 µM for 30 min) was used as a positive control. Fluorescence values were blank-corrected and normalized to the negative control (untreated cells), which was set to 100%. Apoptosis and necrosis analysis in C HDFa and D MCF7 cells following exposure to the same treatments. Statistical analysis was performed using one-way ANOVA followed by Dunnett’s multiple comparison test against the negative control (p < 0.05) and presented as mean ± standard deviation (SD). PVP and AgNO₃ concentrations correspond to the equivalent amounts present in the AgNP formulations. In contrast, treatment with H₂O₂ (200 µM, 30 min) resulted in a marked and statistically significant increase in ROS levels in both HDFa and MCF7 cells, confirming the sensitivity and proper performance of the assay. Interestingly, a modest but statistically significant decrease in ROS signal was observed in PVP-treated MCF7 cells compared with the control. As interference controls were performed and used for background correction, this observation may reflect a minor modulation of the cellular redox state rather than a biological relevant effect. Importantly, this change was not associated with alterations in cell viability, suggesting a limited biological impact under the evaluated conditions. The absence of a significant increase in intracellular ROS levels observed in this study is consistent with previous reports evaluating a similar Argovit®-based AgNP formulation23. For instance, cytotoxicity studies in multiple cancer cell lines have shown that ROS production at IC50 concentrations of PVP-coated AgNPs was not significantly different from untreated controls, although higher nanoparticle concentrations induced measurable oxidative stress responses. These findings suggest that oxidative stress may not represent the dominant mechanism of cytotoxicity under sublethal exposure conditions and that alternative cellular stress responses may play a more relevant role in mediating cellular responses to AgNP exposure. In addition to ROS measurements, apoptosis and necrosis were evaluated to determine whether AgNP exposure induced classical cell death mechanisms in HDFa and MCF7 cells. Under the tested conditions, no significant increases in apoptotic or necrotic cell populations were detected in either cell line following exposure to AgNP1 or AgNP2 compared with untreated controls (Fig. 8C and D). However, a significant increase in necrotic cell populations was observed in MCF7 cells treated with AgNO₃. This effect may be attributed to the higher reactivity and immediate bioavailability of ionic silver at the tested concentrations. Moreover, these results indicate that exposure to AgNP1 and AgNP2 at the concentrations evaluated did not trigger detectable levels of apoptosis or necrosis. Consistent with previous observations for similar PVP-coated silver nanoparticle formulations, increased levels of apoptosis and necrosis have been reported in several cancer cell lines, including MCF7 cells, particularly at higher nanoparticle concentrations23. Together, these observations suggest that the induction of classical cell death pathways by AgNPs may depend strongly on NP dose and exposure conditions. Collectively, these functional assessments are consistent with the transcriptomic findings, indicating that cellular responses to AgNP formulations are predominantly characterized by adaptive stress responses rather than by oxidative damage or classical programmed cell death pathways. These results further support a model in which AgNP exposure under sublethal conditions triggers cell type–dependent regulatory responses, in agreement with the gene- and pathway-level alterations described above. Conclusions This study provides a comparative evaluation of the cytotoxic and transcriptomic effects of two PVP-coated silver nanoparticle formulations (AgNP1 and AgNP2) in human dermal fibroblasts (HDFa) and breast cancer cells (MCF7). Our results demonstrate that cellular responses to AgNP exposure are strongly dependent on cell type and AgNPs physicochemical properties, leading to distinct but partially overlapping molecular mechanisms. Although both formulations induced common stress-related responses, clear differences were observed between cell types. Importantly, even subtle physicochemical differences between AgNP1 and AgNP2, such as variations in hydrodynamic size and polymer characteristics, were sufficient to produce distinct transcriptional and pathway-level responses, highlighting the sensitivity of cellular systems to small changes in NP design. HDFa cells predominantly exhibited a proteostasis-centered response, characterized by translation reprogramming and activation of stress-adaptive pathways, whereas MCF7 cells showed a stronger engagement of cell cycle regulation, RNA processing, and cytoskeletal remodeling pathways, indicating distinct regulatory strategies to manage nanoparticle-induced stress. Importantly, both transcriptomic and functional analyses revealed that AgNP1 and AgNP2 do not primarily induce classical cytotoxic mechanisms such as oxidative stress or apoptosis under the evaluated conditions. Instead, the cellular responses were dominated by adaptive stress pathways, including modulation of translation, cell cycle control, and structural organization. These findings suggest that AgNP exposure under sublethal conditions triggers context-dependent regulatory responses rather than immediate cell death. Furthermore, the limited effects observed for AgNO₃ and PVP, compared to the more pronounced responses induced by AgNP formulations, indicate that the biological activity of these nanomaterials arises from their emergent physicochemical properties at the nanoscale, rather than from ionic or polymeric components alone. Altogether, these findings highlight the importance of integrating transcriptomic and functional approaches to better understand NP–cell interactions and emphasize that AgNP-induced effects cannot be generalized across cell types, as summarized in Fig. 9. While the results provide insight into the molecular responses induced by AgNP formulations, further studies will be required to validate these mechanisms at the protein and functional levels. Graphical Summary of cell-type-specific responses to AgNP1 and AgNP2, AgNO3 and PVP. The schematic illustrates distinct adaptive stress responses induced by AgNP formulations in HDFa and MCF7 cells. In HDFa cells, responses are characterized by proteostasis imbalance and translation reprogramming, whereas MCF7 cells exhibit modulation of cell cycle regulation, RNA processing, and cytoskeletal remodeling pathways. Notably, these effects occur in the absence of predominant oxidative stress or classical apoptosis/necrosis pathway activation, highlighting context-dependent cellular adaptation to nanoparticle exposure. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1. Acknowledgements This work was supported by Azure sponsorship credits granted by Microsoft’s AI for Good Research Lab. Rocio Alejandra Chavez-Santoscoy is part of the Food Security-Health Research Group at Tecnologico de Monterrey. Abbreviations Silver nanoparticles Next-generation sequencing Human dermal fibroblast 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Lactate dehydrogenase release RNA sequencing Surface plasmon resonance Dulbecco’s modified Eagle’s medium Fetal Bovine Serum Differential gene expression Ingenuity Pathway Analysis Dynamic light scattering Polydispersity index Silver nitrate RNA Integrity Number Gene Ontology Biological processes Molecular functions Cellular components Heat shock proteins Differentially expressed proteins Heme oxygenase 1 Nitric Oxide Synthase 3 Nitric oxide Torsin family 1 member A Endoplasmic reticulum Ribosomal protein SA Eukaryotic translation initiation factor 2 subunit gamma CCHC-Type zinc finger nucleic acid binding protein Immunoglobulin kappa j region Forkhead box N1 Receptor interacting serine/threonine Kinase 2 Spondin 2 Chromobox homolog 2 Caspase recruitment domain cAMP-response element-binding protein Eukaryotic initiation factor-2 Serine and arginine rich splicing factor 3 Zinc finger matrin-type 2 LUC7 like 3 pre-mRNA splicing factor Ras-related nuclear protein Differentially expressed genes Extracellular matrix Base excision repair Selectivity index Base excision repair Author contributions González-Vega: Conceptualization, Writing-original draft, review and editing. Fabian-Ortiz: Conceptualization, Writing-original draft, Review and Editing, Magallón-Gayón: Review and Editing. Vázquez-Garza Eduardo, Flow cytometry assay standardization, data collection, analysis and validation, Torres-Esquivel JP, Data collection and analysis, Hinojosa-Alvarez: Review and Editing. Hernandez-Perez: Review and Editing. Nina Bogdanchikova: Review and Editing. Alexey Pestryakov: Review and Editing. Chavez-Santoscoy: Review and Editing, Conceptualization, Writing-original draft, Supervision, Funding acquisition. Funding This work was supported by Azure sponsorship credits granted by Microsoft’s AI for Good Research Lab. Rocio Alejandra Chavez-Santoscoy is part of the Food Security-Health Research Group at Tecnologico de Monterrey and wants to thank the Challenge-Based Research Funding Program at Tecnológico de Monterrey since this program funded the entire project in the grant with number E004 - EIC-TM – 10-372. Authors also acknowledge SECIHTI for financial support through the project CBF-2025-G-82. Data availability Data are provided within the manuscript or supplementary information files. Declarations Competing interests The authors declare no competing interests. Ethical approval and consent to participate Not applicable. Consent for publication Not applicable. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. These authors contributed equally: Jesús Gabriel González-Vega and Emilio Fabian-Ortiz. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement Data are provided within the manuscript or supplementary information files.